M. were divided into six equal aliquots given at four-hour intervals. Two aliquots were given as priming doses before, and the third simultaneously with the intramuscular dose of penicillin. The largest daily dose, 20 Gm./sq. M., was divided into eight equal aliquots given at three-hour intervals with three aliquots given as priming doses, and the fourth with the penicillin. This different interval was used in order to reduce the size of individual aliquots at this high dosage level.
It has been shown by Beyer et al. in a recent series of papers ( 1 to 4) that the compound 4-carboxyphenylmethanesulfonanilide, known as Caronamide, is effective in increasing the penicillin plasma concentration and in prolonging the period of time over which detectable penicillin plasma concentrations are maintained following administration of penicillin, orally and by venoclysis, to dogs. In these experiments it was demonstrated that the renal tubular excretion of penicillin could be completely suppressed (2) when the antibiotic was given concomitantly with adequate amounts of Caronamide.
In a series of experiments in children (5), Caronamide used in conjunction with penicillin administered orally was effective in increasing the penicillin plasma concentration from 2.8-to 14.5-fold over the penicillin controls and was also found to be of a low order of toxicity at the dosages employed.
The purpose of the present research was to determine an optimum dose of Caronamide for children.
METHODS
Method of administration. Afebrile convalescent patients, aged two to nine years, with normal renal function were selected. Single doses of approximately 300,000 units of penicillin/sq. M. -of body surface (equivalent to approximately 10,000 units/Kg. of body weight) were given intramuscularly as a control, and blood was drawn 1This study was supported by a grant-in-aid from Sharp & Dohme, Inc. 2 The Caronamide used in this study was supplied by Dr. Karl Beyer of the Research Department of Sharp & Dohme, Inc. 8 The'Sharp & Dohme proprietary name for this compound is now "Staticin" Caronamide. 4 Some of the penicillin used in this study was kindly supplied by Commercial Solvents Company, Ltd. for assay at intervals of one-half,5 one, three, five and seven hours after administration. The penicillin used was the regular crystalline commercial variety containing 90 per cent penicillin G. One of the authors always made the dilutions (with physiologic saline) and administered the dose. At intervals of two days thereafter, the same patients received the same dose of penicillin intramuscularly together with Caronamide orally, the Caronamide dosage being increased on each successive trial. The daily dose of Caronamide ranged from 5 to 20 Gm./ sq. M./24 hours. The daily doses of 5, 10, and 15 Gm./ sq. M. were divided into six equal aliquots given at four-hour intervals. Two aliquots were given as priming doses before, and the third simultaneously with the intramuscular dose of penicillin. The largest daily dose, 20 Gm./sq. M., was divided into eight equal aliquots given at three-hour intervals with three aliquots given as priming doses, and the fourth with the penicillin. This different interval was used in order to reduce the size of individual aliquots at this high dosage level.
Method of assay. A modified Rammelkamp assay technique (6) was employed, using half-step dilutions of the test plasma with a hemolytic streptococcus 6 as the test organism.
RESULTS
The object of this study was to determine how great a dose of Caronamide is required to suppress completely the tubular excretion of penicillin, reducing it to that of glomerular filtration alone. Since the measurement of direct clearance values was impracticable, the results were obtained by indirect means.
Eagle and Newman (7) have shown that the renal clearance of penicillin approximates the total renal plasma flow and is four to five times greater than the glomerular filtration alone. In other words, 20 Tables I and II .) 8 The formulae used for calculating (1) the slope of the decrease of the measured plasma penicillin levels and (2) the slope of the calculated decrease of penicillin levels expected with glomerular filtration alone, are given below.
In both, K = the constant rate of clearance of the extracellular fluid of penicillin by the kidney in a given unit of time.
The standard formula (15) As previously mentioned, the Caronamide dosage was based on the body surface area as a unit of measurement because this is known to be more closely correlated with renal function than is body weight. Since, however, this is an uncommon unit in clinical practice, it was thought advisable to recalculate the doses in terms of body weight. Figure 3 Figure 4 . A few individuals, such as the one shown in Figure 5 riod, whereas a consistently good reactor (patient A. A., Figure 1 ) showed a 24-hour excretion of 60 per cent and 67 per cent of ingested Caronamide, respectively, in two trials. In the poor reactor (patient M. E.) no Caronamide was demonstrated in the plasma in two out of three trials; a plasma concentration of less than 5 mg. per cent on the third trial was present. In adults, Boger (9) has shown that a plasma Caronamide concentration of 20 to 40 mg. per cent was required to give satisfactory blocking of the tubular excretion of penicillin. Of a total of 23 trials (15 patients the excretion of penicillin given intravenously is at the same rate as that given intramuscularly. An identical result was obtained in three different patients. Toxicity In this study, toxicity of Caronamide was found to be of a very low order, confirming the impression obtained in earlier work (5) . Toxic reactions were encountered on only five occasions out of the 59 tests conducted on 21 patients. In four patients, these consisted of anorexia, nausea and vomiting, and then only at doses higher than the dose range now considered advisable. In three of these children, there was no reaction with high daily doses given at four-hour intervals, but the same daily dose given at six-hour intervals with correspondingly larger individual doses produced nausea and vomiting. In the fifth patient a transient macular itching rash appeared over the face, neck, and shoulder girdle after nine doses of Caronamide. This began to fade four hours after discontinuing the drug and had disappeared within 36 hours. 
DISCUSSION
The data presented suggest that in children of the age range studied, two to nine years, complete or almost complete suppression of the tubular excretion of penicillin can be achieved in over 85 per cent by the oral administration of optimal doses of Caronamide. The result of such a suppression is to raise the plasma concentration of penicillin at any given dose and to prolong the time during which such a level is maintained. It would appear that in clinical medicine this fact would be valuable in a situation where the patient is infected with a comparatively resistant organism, since very high blood levels can be attained and maintained by suitably adjusting the size and frequency of penicillin administration in conjunction with the recommended dosage of Caronamide. This treatment has been used effectively for resistant cases of subacute bacterial endocarditis (10, 11) . It also may be of'value in reducing the need for frequent doses of penicillin by prolonging the maintenance ,2a theoretically effective blood level for organisms of all degrees of sensitivity. A single dose of penicillin per 24 hours may be sufficient for very sensitive organisms. The results of Zubrod's work (12) suggest, however, that infrequent but large doses of penicillin may be effective therapeutically without the addition of Caronamide. It is not within the scope of this paper to discuss the best clinical application of these data since this must be determined by actual clinical trial. It may well be that smaller doses of Caronamide, at longer intervals, giving less than complete tubular suppression will be entirely adequate for the treatment of most infections. On the other hand, 'it seems more probable that the need for Caronamide may be confined to those situations just mentioned, in which very high and prolonged blood levels are needed for the therapy of infections by resistant organisms. With the recent development of a method for determining blood levels of Caronamide, a closer correlation between therapeutic effect and blood levels will be possible. Using this method, Boger (9) has found that there is a tendency for Caronamide to accumulate in the blood so that the dosage schedules may have to be adjusted according to blood levels. Also some method may be found of improving the absorption of Caronamide from the intestinal tract and thus make the drug valuable to the 15 per cent of patients who now fail, temporarily or permanently, to respond. In this study, no attempt has been made to evaluate the dosage for infants under two years of age. The recognized inefficiency of the immature kidneys of infants up to six months at least (13) would suggest that smaller doses of Caronamide would be needed in this age-group to effect the same results on the, penicillin excretion rate. 
